CIK: 1185945 - Address: C/O Fennec Pharmaceuticals, Inc., Po Box 13628, 68 Tw Alexander Drive, Research Triangle Park, NC 27709
20 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

4/15/24 18:15
4/15/24
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagRallis Chris ANCDS.d-810.450-1-246D
4/15/24 18:15
4/15/24
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagRallis Chris ANCDM.d1510.4501346D
3/27/24 16:24
3/26/24
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagRallis Chris ANCDS.d-2310.970-2-445D
3/27/24 16:24
3/26/24
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagRallis Chris ANCDM.d102.31041145D
12/28/23 16:02
12/26/23
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagRallis Chris ANCDS.d-1510.900-1-346D
12/28/23 16:02
12/26/23
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagRallis Chris ANCDM.d51.5903746D
11/20/23 21:20
11/20/23
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagRallis Chris ANCDS-28.2500-143D
8/18/23 17:00
8/18/23
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagRallis Chris ANCDS-57.850-1-243D
7/24/23 17:04
7/24/23
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagRallis Chris ANCDM.d120.72000176144D
7/24/23 17:04
7/24/23
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagRallis Chris ANCDS.d-568.170-7-1344D
7/6/23 17:20
7/6/23
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagRallis Chris ANCDS.d-198.470-2-634D
7/6/23 17:20
7/6/23
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagRallis Chris ANCDM.d50.9600051834D
5/19/23 16:41
5/19/23
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagRallis Chris ANCDS-137.360-2-531D
4/17/23 21:25
4/17/23
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagRallis Chris ANCDM52.9402533D
3/3/23 17:35
3/3/23
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagRallis Chris ANCDM102.40041532D
11/17/22 16:09
11/17/22
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagRallis Chris ANCDS-37.9900-130D
10/20/22 16:15
10/20/22
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagRallis Chris ANCDM51.05051930D
7/18/22 18:00
7/18/22
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagRallis Chris ANCDM50.45000116728D
3/8/22 08:24
3/8/22
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagRallis Chris ANCDM100.568401852821D
10/21/21 15:40
10/21/21
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagRallis Chris ANCDM51.5003New3D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact